Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 10;317(5):620-31.
doi: 10.1016/j.yexcr.2010.12.017.

CXCR3 in T cell function

Affiliations

CXCR3 in T cell function

Joanna R Groom et al. Exp Cell Res. .

Abstract

CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4(+) T cells and effector CD8(+) T cells. CXCR3 is activated by three interferon-inducible ligands CXCL9 (MIG), CXCL10 (IP-10) and CXCL11 (I-TAC). Early studies demonstrated a role for CXCR3 in the trafficking of Th1 and CD8 T cells to peripheral sites of Th1-type inflammation and the establishment of a Th1 amplification loop mediated by IFNγ and the IFNγ-inducible CXCR3 ligands. More recent studies have also suggested that CXCR3 plays a role in the migration of T cells in the microenvironment of the peripheral tissue and lymphoid compartment, facilitating the interaction of T cells with antigen presenting cells leading to the generation of effector and memory cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Model for Interferon-CXCR3 chemokine ligand-dependent inflammatory amplification in the periphery
This model describes the sequential events from left (1) to right (7) involving Type I and Type II interferon and the CXCR3 ligands, CXCL9 and CXCL10, in the initiation, amplification and resolution of Th1-type inflammation in the periphery. Open arrowheads indicate cytokine/chemokine secretion and closed arrowheads indicate cellular movements.
  1. Initial innate challenge, such as bacterial or viral infection, activates TLRs and RNA helicases leading to the release of IFNα/β and subsequent secretion of chemokines, predominantly CXCL10.

  2. CXCL10 recruits CD4+ Th1 cells and possibly NK cells into the target tissue.

  3. DCs in the tissue present antigen to CD4+ Th1 cells, which in turn secrete IFNγ.

  4. Tissue resident DCs and other cells take up IFNγ leading to secretion of CXCL9 and CXCL10.

  5. CXCL9 and CXCL10 recruit CD8+ CTLs into the tissue

  6. Migrated CD8+ CTLs secrete IFNγ, further stimulating tissue resident cells to produce more CXCL9 and CXCL10.

  7. Increased chemokine release amplifies inflammation, leading to further recruitment of CXCR3-expressing Th1 T cells and CTLs.

  8. Increased inflammation can also attract in CTLs in a CXCR3-independent manner.

  9. CXCR3-expressing CD4+ Treg cells may also enter the tissue, to counterbalance the CTL and Th1 cell response and lead to resolution of Th1 inflammation.

References

    1. Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 2008;9:970–980. - PubMed
    1. Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD. Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J Immunol. 2006;177:6991–6998. - PubMed
    1. Campanella GS, Medoff BD, Manice LA, Colvin RA, Luster AD. Development of a novel chemokine-mediated in vivo T cell recruitment assay. J Immunol Methods. 2008;331:127–139. - PMC - PubMed
    1. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187:2009–2021. - PMC - PubMed
    1. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol. 1998;28:3696–3705. - PubMed

Publication types

Substances